Valeant, Ackman Bid for Botox Maker for $46 Billion

The Wall Street Journal
April 22, 2014 AT 10:35 AM
Valeant Pharmaceuticals has enlisted investor William Ackman in its attempt to acquire rival Allergan, a $46 billion deal that would create a Big Pharma behemoth. But the details of the Ackman/Valeant alliance are as interesting as the deal itself. WSJ's Dana Mattioli explains on MoneyBeat.